Showing 1 - 10 of 15
AFP, Published on 11/07/2023
» NICOSIA - A sickly ginger kitten named Bebe is pulled out of a cat carrier at a veterinary clinic in the Cypriot capital, Nicosia.
AFP, Published on 22/04/2022
» GENEVA: The World Health Organization said Friday it "strongly recommended" Pfizer's Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.
AFP, Published on 23/12/2021
» WASHINGTON: The US Food and Drug Administration (FDA) on Thursday authorised Merck's Covid pill for high risk adults, a day after giving the green light to a similar pill by Pfizer.
AFP, Published on 22/12/2021
» PARIS: France started vaccinating children over five and China plunged a city into a strict lockdown on Wednesday as governments scramble to contain fresh virus surges driven by the Omicron variant.
AFP, Published on 15/12/2021
» WASHINGTON: Pfizer said Tuesday that clinical trials confirmed its Covid pill -- a new type of treatment that should withstand the mutations seen with the Omicron variant -- drastically reduced hospitalizations and deaths among at-risk people by almost 90 percent.
AFP, Published on 14/12/2021
» WASHINGTON - Pfizer said Tuesday that clinical trials confirmed its Covid pill, a new type of antiviral treatment that should withstand the mutations seen with Omicron, drastically reduced hospitalizations and deaths among at-risk people by almost 90 percent.
AFP, Published on 03/12/2021
» PARIS: After a year of vaccines aimed at preventing Covid, treatments for people infected with the virus are few, with most restricted to hospital use and extremely pricey.
AFP, Published on 01/12/2021
» WASHINGTON - A panel of US health experts on Tuesday voted to recommend Merck's Covid pill for high-risk adults -- a new form of treatment that is easy to administer and could prove better able to withstand variants, including Omicron.
AFP, Published on 27/11/2021
» WASHINGTON - An anti-Covid pill developed by Merck has proved effective in treating the disease, the US Food and Drug Administration said Friday in a much-awaited preliminary report.
AFP, Published on 17/11/2021
» GENEVA: US pharmaceutical giant Pfizer on Tuesday announced a deal to make its prospective antiviral Covid-19 pill available more cheaply in the world's least-wealthy countries.